JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW
21,100
-1,300 (-5.80%)
At close: Mar 28, 2025, 3:30 PM KST
JW Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 502,027 | 561,695 | 828,523 | 419,688 | 505,678 | 753,056 | |
Market Cap Growth | -32.20% | -32.20% | 97.41% | -17.00% | -32.85% | 22.16% | |
Enterprise Value | 561,202 | 600,784 | 959,912 | 491,395 | 649,827 | 873,041 | |
Last Close Price | 21450.00 | 24000.00 | 34877.84 | 17456.16 | 20654.29 | 30394.81 | |
PE Ratio | 7.69 | 8.64 | 22.39 | 13.16 | - | - | |
Forward PE | 6.40 | 26.79 | 26.79 | 26.79 | 26.79 | 26.79 | |
PS Ratio | 0.70 | 0.78 | 1.11 | 0.61 | 0.83 | 1.38 | |
PB Ratio | 1.52 | 1.71 | 3.12 | 1.86 | 2.68 | 3.63 | |
P/TBV Ratio | 1.76 | 1.76 | 3.29 | 1.84 | 2.68 | 3.86 | |
P/FCF Ratio | 7.03 | 7.90 | 13.84 | 8.96 | 47.45 | 14.86 | |
P/OCF Ratio | 7.08 | 7.08 | 9.51 | 7.39 | 27.90 | 11.94 | |
EV/Sales Ratio | 0.78 | 0.84 | 1.28 | 0.72 | 1.07 | 1.60 | |
EV/EBITDA Ratio | 5.44 | 5.90 | 8.05 | 6.36 | 13.84 | 45.08 | |
EV/EBIT Ratio | 6.67 | 7.26 | 9.93 | 8.12 | 21.07 | - | |
EV/FCF Ratio | 7.90 | 8.45 | 16.03 | 10.49 | 60.98 | 17.23 | |
Debt / Equity Ratio | 0.28 | 0.28 | 0.64 | 0.93 | 1.30 | 0.88 | |
Debt / EBITDA Ratio | 0.90 | 0.90 | 1.43 | 2.71 | 5.22 | 9.41 | |
Debt / FCF Ratio | 1.29 | 1.29 | 2.84 | 4.47 | 23.00 | 3.60 | |
Asset Turnover | 1.15 | 1.15 | 1.18 | 1.09 | 1.03 | 0.98 | |
Inventory Turnover | 3.64 | 3.64 | 3.79 | 3.70 | 3.65 | 3.86 | |
Quick Ratio | 0.82 | 0.82 | 0.90 | 0.80 | 0.79 | 0.78 | |
Current Ratio | 1.47 | 1.47 | 1.32 | 1.12 | 1.30 | 1.27 | |
Return on Equity (ROE) | 21.87% | 21.87% | 15.65% | 14.41% | -0.73% | -6.98% | |
Return on Assets (ROA) | 8.28% | 8.28% | 9.49% | 6.00% | 3.26% | -0.15% | |
Return on Capital (ROIC) | 12.07% | 12.07% | 13.87% | 8.70% | 4.68% | -0.21% | |
Return on Capital Employed (ROCE) | 20.90% | 20.90% | 27.00% | 24.40% | 8.80% | - | |
Earnings Yield | 12.96% | 11.58% | 4.47% | 7.60% | -0.19% | -2.02% | |
FCF Yield | 14.16% | 12.65% | 7.23% | 11.16% | 2.11% | 6.73% | |
Dividend Yield | 2.17% | 1.88% | - | - | - | - | |
Payout Ratio | 14.86% | 14.86% | 23.82% | 23.05% | - | - | |
Buyback Yield / Dilution | 2.01% | 2.01% | -2.49% | -0.07% | 0.05% | -0.04% | |
Total Shareholder Return | 4.18% | 3.89% | -2.49% | -0.07% | 0.05% | -0.04% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.